Back

Safety and efficacy of persistent atrial fibrillation ablation using the second generation cryoballoon

18 March 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 3 - Atrial fibrillation ablation - Cryoballoon Rhythm Control, Catheter Ablation EHRA Premium Access EHRA 2018

About the speaker

Photo
Doctor Kivanc Yalin

Istanbul University Cerrahpasa, Istanbul (Turkiye)

11 More presentations in this session

Presentation thumbnail
Is the cryoablation an effective treatment for paroxysmal AF patients with structural heart disease? Clinical outcomes from multicenter observational project
Doctor G. Perego (Milan, IT)
Abstract
Presentation thumbnail
Safety, acute efficacy, and long-term clinical outcomes using the second-generation cryoballoon for pulmonary vein isolation in patients with pulmonary vein abnormality
Doctor K. Yalin (Istanbul, TR)
Abstract
Presentation thumbnail
Starting atrial fibrillation ablation program: a comparison between second generation cryoballoon and contact force sensing radiofrequency catheters
Associate Professor V. Velagic (Zagreb, HR)
Abstract Slides
Presentation thumbnail
The second generation cryoballoon ablation is safe and useful for paroxysmal atrial fibrillation in super-elderly patients over 80 years: a report from two high-volume centers
Doctor T. Yoshizawa (Kyoto, JP)
Abstract
Presentation thumbnail
Frequency of phrenic nerve injury following cryo balloon and radio frequency ablations: a systematic review

Access the full session

Session thumbnail
Poster session 3 - Atrial fibrillation ablation - Cryoballoon

The Event

Event poster

EHRA 2018

18 March - 20 March 2018

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources